Education
About Us
Working with TipRanks
Follow Us
Earnings Calendar - Mar 26, 2024
Showing earnings announcements on Mar 26, 2024
Name | Company | Market Cap | EPS (Forecast) | EPS (Actual) | Revenue (Forecast) | Revenue (Actual) | Time | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
 | GameStop | $14.77B | $0.29 | $2.05B | xxxxxxxxxxxxx | |||||
 | Bluebird Bio | $48.86M | -$13.13 | $16.78M | xxxxxxxxxxxxx | |||||
 | BYD Company | $176.68B | $0.82 | $27.62B | ― | xxxxxxxxxxxxx | ||||
 | Bioline RX Ltd Sponsored ADR | $13.80M | -$8.84 | $150.00K | xxxxxxxxxxxxx | |||||
 | McCormick & Company | $19.07B | $0.58 | $1.55B | xxxxxxxxxxxxx | |||||
 | Annexon Biosciences | $231.50M | -$0.44 | $0.00 | xxxxxxxxxxxxx | |||||
 | Biora Therapeutics | $610.57K | -$5.95 | $0.00 | xxxxxxxxxxxxx | |||||
 | Ouster | $553.55M | -$0.60 | $24.06M | xxxxxxxxxxxxx | |||||
 | GDS Holdings | $5.47B | -$0.35 | $359.04M | xxxxxxxxxxxxx | |||||
 | PaySign | $183.26M | $0.02 | $12.36M | xxxxxxxxxxxxx | |||||
 | Velo3D | $88.30M | -$2.80 | $19.50M | xxxxxxxxxxxxx | |||||
 | Gyre Therapeutics | $764.72M | -$0.60 | ― | $0.00 | ― | xxxxxxxxxxxxx | |||
 | TD SYNNEX Corporation | $10.19B | $2.84 | $14.36B | xxxxxxxxxxxxx | |||||
 | Vivani Medical | $66.95M | -$0.14 | ― | xxxxxxxxxxxxx | |||||
 | nCino | $3.03B | $0.12 | $124.68M | xxxxxxxxxxxxx | |||||
 | DouYu International Holdings | $201.29M | -$0.24 | $171.52M | xxxxxxxxxxxxx | |||||
 | Delcath Systems | $561.05M | -$0.54 | $548.00K | xxxxxxxxxxxxx | |||||
 | Palladyne AI Corp | $265.35M | -$0.44 | $1.00M | ― | xxxxxxxxxxxxx | ||||
 | Kyverna Therapeutics, Inc. | $98.11M | -$0.70 | $0.00 | xxxxxxxxxxxxx | |||||
 | NovaBay Pharma | $3.31M | -$10.50 | $3.40M | xxxxxxxxxxxxx | |||||
 | OpGen | $47.32M | -$0.25 | ― | $1.00M | ― | ― | xxxxxxxxxxxxx | ||
 | Progress Software | $2.63B | $1.14 | $181.91M | xxxxxxxxxxxxx | |||||
 | BioAtla | $22.78M | -$0.79 | $0.00 | xxxxxxxxxxxxx | |||||
 | Flutter Entertainment PLC | $42.58B | $2.07 | $3.38B | xxxxxxxxxxxxx | |||||
 | PAVmed | $11.19M | -$1.63 | $1.05M | xxxxxxxxxxxxx | |||||
 | Aprea Therapeutics | $9.24M | -$0.77 | $165.00K | xxxxxxxxxxxxx | |||||
 | Concentrix | $3.56B | $2.58 | $2.38B | xxxxxxxxxxxxx | |||||
 | Korro Bio | $129.59M | -$3.53 | $0.00 | xxxxxxxxxxxxx | |||||
 | Intrusion | $29.44M | -$2.20 | $1.64M | xxxxxxxxxxxxx | |||||
 | Acumen Pharmaceuticals | $61.78M | -$0.27 | $15.00M | xxxxxxxxxxxxx | |||||
 | AEye Inc | $15.11M | -$1.20 | $100.00K | xxxxxxxxxxxxx | |||||
 | Vigil Neuroscience Inc | $368.24M | -$0.53 | $0.00 | xxxxxxxxxxxxx | |||||
 | Logan Ridge Finance | $47.06M | $0.35 | $5.00M | xxxxxxxxxxxxx | |||||
 | Direct Digital Holdings | $8.89M | $0.26 | $65.95M | xxxxxxxxxxxxx | |||||
 | Cognition Therapeutics | $18.41M | -$0.32 | $0.00 | xxxxxxxxxxxxx | |||||
 | Gain Therapeutics | $53.20M | -$0.31 | $250.00K | xxxxxxxxxxxxx | |||||
 | Panbela Therapeutics | $1.15M | -$24.34 | $0.00 | xxxxxxxxxxxxx | |||||
 | GT Biopharma | $7.47M | -$2.70 | ― | ― | xxxxxxxxxxxxx | ||||
 | US Energy | $45.55M | -$0.02 | $8.82M | xxxxxxxxxxxxx | |||||
 | Virpax Pharmaceuticals | $285.78K | -$75.00 | ― | xxxxxxxxxxxxx | |||||
 | Noah Holdings | $650.74M | ― | ― | xxxxxxxxxxxxx | |||||
 | Forge Global Holdings | $169.51M | -$1.57 | $19.59M | xxxxxxxxxxxxx | |||||
 | Kenon | $1.73B | ― | ― | xxxxxxxxxxxxx | |||||
 | Movado Group | $264.92M | ― | $174.80M | xxxxxxxxxxxxx | |||||
 | Alvotech | $3.10B | ― | ― | ― | ― | xxxxxxxxxxxxx | |||
 | Iridex | $16.45M | -$0.05 | $14.90M | xxxxxxxxxxxxx | |||||
 | Ryvyl | $5.12M | -$0.40 | $18.00M | xxxxxxxxxxxxx | |||||
 | Zhihu | $355.78M | -$0.23 | $148.95M | xxxxxxxxxxxxx | |||||
 | X Financial | $448.03M | ― | ― | xxxxxxxxxxxxx | |||||
 | Greentree Hospitality Group | $132.89M | $0.03 | $52.73M | xxxxxxxxxxxxx | |||||
 | JBS SA | $16.33B | $0.17 | $18.69B | xxxxxxxxxxxxx | |||||
 | LianBio Sponsored ADR | $38.91M | -$0.19 | $0.00 | ― | xxxxxxxxxxxxx | ||||
 | Waterdrop | $394.06M | $0.01 | $94.41M | xxxxxxxxxxxxx | |||||
 | Atos SE | $821.52M | $59.39 | $5.86B | xxxxxxxxxxxxx | |||||
 | Cadeler A/S Sponsored ADR | $1.74B | -$0.35 | $38.82M | xxxxxxxxxxxxx | |||||
 | Smiths Group | $9.62B | $0.61 | $1.93B | xxxxxxxxxxxxx | |||||
 | Third Harmonic Bio, Inc. | $233.76M | -$0.31 | $0.00 | xxxxxxxxxxxxx | |||||
 | Semantix | $8.05K | -$0.03 | ― | $39.87M | ― | ― | xxxxxxxxxxxxx | ||
 | Minerva SA | $900.80M | ― | ― | xxxxxxxxxxxxx | |||||
 | WH Group | $11.64B | ― | ― | xxxxxxxxxxxxx | |||||
 | SUPER HI INTERNATIONAL HOLDING LTD. Sponsored ADR | $1.29B | ― | ― | ― | xxxxxxxxxxxxx |
Rows:
Earnings News
FAQ
When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
How do earnings affect stock prices?
A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
Is it better to buy a stock before or after earnings?
Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.